NEW YORK (GenomeWeb News) — Thermo Fisher Scientific has opened an RNAi research and services lab in Lafayette, Colo., the company said today.
The lab will offer contract RNAi screening and analysis services, including high-throughput screening, along with services and research using the company’s bioreagents, robotics, and other instrument systems, the company said.
It will also develop new therapeutic technologies involving RNAi, Thermo said.
Thermo said the lab features its Dharmacon siRNA and miRNA libraries, as well as the BioImage and Cellomics high-content screening reagents and image-analysis instruments.